background image

AI Wars, Nuclear Bets, and the Big Tech Shake-Up: What Saxo Singapore Clients Traded in January

Equities 6 minutes to read

Key points:

  • AI Shake-Up: Nvidia Faces New Threats – Nvidia fell -10.6% as investors locked in gains and China’s DeepSeek AI emerged as a major competitor, offering comparable AI performance at lower costs. Meanwhile, TSMC and ASML proved resilient, benefiting from continued AI chip demand.
  • Big Bets on Nuclear Energy and Space – Oklo surged 96.0% as investors bet on nuclear energy as the next big clean power source, while Intuitive Machines jumped 31.1% on new NASA contracts, fueling excitement around private space exploration.
  • Tech Rotation and Dividend Safety Plays – While SoundHound AI and Rigetti Computing plunged, investors shifted focus to AI infrastructure plays like Oracle and Arm Holdings, driven by Trump’s Stargate AI initiative. Meanwhile, Singapore’s DBS saw rising investor interest, reinforcing demand for dividend-paying stocks amid market volatility.

Most Traded Stocks by Saxo Singapore Clients

January 2025 saw some major shifts in trading activity among Saxo Singapore clients. While tech giants like NVIDIA, Tesla, Palantir, and Advanced Micro Devices continued to dominate, some unexpected names surged in popularity.

Two of the biggest stories this month were again Rigetti Computing and SoundHound AI, which had been high-flyers in December but saw sharp declines in January. SoundHound AI dropped -28.7%, while Rigetti Computing fell -13.7%, as profit-taking and shifting market sentiment took hold.

Nvidia also saw a -10.6% drop, suggesting that investors may be locking in gains after its massive rally last year and the emergence of Chinese AI models like DeepSeek that deliver comparable performance at a fraction of the cost and diminish the barriers to monetize AI with their open source model.

Meanwhile, Palantir, Micron and Taiwan Semiconductor posted strong gains, rising 9.1%, 8.4% and 6.0%, respectively.

4_CHCA_Hot 1
Source: Saxo
4_CHCA_Hot 2
Source: Saxo

Hot Stocks Picked by Saxo Singapore Clients

Beyond the most traded names, several stocks saw a dramatic rise in investor interest. We looked at the most traded stocks, which had more than 100 trades, and ranked them. Then we compared the ranks for this month to last month. This helped us find the stocks that jumped the most in popularity. These stocks indicate our clients’ shifting interests, momentum and their read of the markets.

Netflix led our hot stocks ranking as it reported monster earnings with a massive subscriber growth and increasing revenue from its ad-supported tier. Analysts have turned bullish, believing the company’s cost-cutting measures are finally paying off.

Tech interest also shifted to others like Oracle, TSMC, Arm Holdings and ASML.

TSMC reported strong demand for AI chips and significantly increased capex for 2025, although tariffs threats and DeepSeek competition has taken away some of the cheer. Meanwhile, ASML also reported strong earnings post-DeepSeek, highlighting how AI is still driving growth and reaffirming that cheap AI could be a blessing, not a curse.

Meanwhile, Oracle and Arm Holdings gained popularity due to President Trump’s Stargate initiative for strategic AI infrastructure investments, involving OpenAI, SoftBank and Oracle.

Intuitive Machines also captured attention with 31% gains as it secured new NASA contracts. The excitement around private space exploration has been building, and investors are taking notice.

Other mid-cap names like Oklo and Applied Digital were some of the other surprises on the list.

Oklo’s stock skyrocketed 96.0% in January and saw near 80% jump in trades by Saxo Singapore clients, fueled by investor enthusiasm for nuclear energy. The company secured a long-term power purchase agreement for its microreactors, reinforcing confidence in its long-term potential.

Applied Digital, a power and data center play, fell nearly 7% in January but saw a 50% jump in the number of trades.

Singapore’s banking giant DBS also saw a rise in trading activity, as investors sought yield amid volatile markets. The company is set to report earnings on February 9, making it one to watch.

The final name on the list was Novo Nordisk, which is now down 42% from its June 2024 highs, as weak drug trial results pressured sentiment in the obesity drug market.

4_CHCA_Hot 3
Source: Saxo
4_CHCA_Hot 4
Source: Saxo

What January’s Trading Trends Reveal

The AI Wars Are Just Beginning

The rise of China’s DeepSeek AI is shaking up the market, as investors question whether Nvidia’s pricing power can hold up. Meanwhile, AI hardware players like TSMC and ASML are proving resilient, even as software stocks like SoundHound AI struggle.

Nuclear Energy and Space Are the New Speculative Bets

Oklo’s 96% rally and Intuitive Machines’ 31% jump indicate investors are betting on nuclear power and private space exploration as long-term growth themes.

Big Tech Rotation: From AI Hype to Infrastructure Plays

Oracle and Arm Holdings gained steam, benefiting from Trump’s AI infrastructure investments, while Netflix surged on improving fundamentals.

Dividend Stocks Are Still in Demand

The rise in DBS trading volume highlights investors’ search for stable income in uncertain markets. With its earnings report on February 9, investors are watching closely.


What to Watch in February

Will DeepSeek AI put more pressure on Nvidia and U.S. chipmakers? Will nuclear energy stocks like Oklo continue their rally? How will Singapore’s DBS fare in its earnings report?

With earnings season heating up, February could bring another wave of surprises. Stay tuned for next month’s update.

 

 

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.